Showing results (201-210 of 276) with videos related to
Sort By:
Pageof 28
Blood Advances|December 12, 2018
p53 regulates CD46 expression and measles virus infection in myeloma cellsAnne Lok, Geraldine Descamps, Benoit Tessoulin, et al.Experimental Hematology|July 30, 2014
Human herpesvirus 6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adultsAmandine Le Bourgeois, Myriam Labopin, Thierry Guillaume, et al.Annals of Hematology|April 5, 2017
Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/-R) is an effective treatment with low toxicity in Hodgkin's and non-Hodgkin's lymphomasB Tessoulin, P Thomare, E Delande, et al.The Lancet. Haematology|July 13, 2019
Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 studyFranck Morschhauser, Steven Le Gouill, Pierre Feugier, et al.Scientific Reports|September 22, 2020
Antithymocyte globulin administration in patients with profound lymphopenia receiving a PBSC purine analog/busulfan-based conditioning regimen allograftMaxime Jullien, Thierry Guillaume, Pierre Peterlin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 18, 2023
Long-Term Follow-Up of Rituximab Maintenance in Young Patients With Mantle-Cell Lymphoma Included in the LYMA Trial: A LYSA StudyClémentine Sarkozy, Catherine Thieblemont, Lucie Oberic, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2010
High rates of durable responses with anti-CD22 fractionated radioimmunotherapy: results of a multicenter, phase I/II study in non-Hodgkin's lymphomaFranck Morschhauser, Françoise Kraeber-Bodéré, William A Wegener, et al.Blood|October 29, 2008
High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 yearsEmmanuel Gyan, Charles Foussard, Philippe Bertrand, et al.Leukemia & Lymphoma|August 20, 2011
Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 10th annual conference of the European Mantle Cell Lymphoma NetworkMartin Dreyling, Hanneke C Kluin-Nelemans, Sílvia Beà, et al.Cancer Medicine|September 21, 2021
Impact of allogeneic stem cell transplantation comorbidity indexes after haplotransplant using post-transplant cyclophosphamideMaxime Jullien, Corentin Orvain, Ana Berceanu, et al.Pageof 28